Cumberland Partners Ltd Cuts Holdings in McKesson Corporation $MCK

Posted by Brenda Bartman on May 23rd, 2026

Cumberland Partners Ltd trimmed its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 23.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,025 shares of the company’s stock after selling 2,415 shares during the period. Cumberland Partners Ltd’s holdings in McKesson were worth $6,583,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Meiji Yasuda Asset Management Co Ltd. boosted its stake in McKesson by 0.5% during the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,262 shares of the company’s stock valued at $1,855,000 after purchasing an additional 11 shares during the last quarter. Obsidian Personal Planning Solutions LLC boosted its stake in McKesson by 2.9% during the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock valued at $346,000 after purchasing an additional 12 shares during the last quarter. LRI Investments LLC boosted its stake in McKesson by 12.1% during the 4th quarter. LRI Investments LLC now owns 111 shares of the company’s stock valued at $91,000 after purchasing an additional 12 shares during the last quarter. Macroview Investment Management LLC boosted its stake in shares of McKesson by 3.9% in the 4th quarter. Macroview Investment Management LLC now owns 322 shares of the company’s stock worth $264,000 after buying an additional 12 shares during the last quarter. Finally, Berkshire Asset Management LLC PA boosted its stake in shares of McKesson by 4.6% in the 3rd quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock worth $227,000 after buying an additional 13 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. This trade represents a 45.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on MCK shares. JPMorgan Chase & Co. dropped their price target on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Citigroup dropped their price target on McKesson from $975.00 to $945.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. UBS Group raised their price target on McKesson from $1,000.00 to $1,050.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Morgan Stanley restated an “overweight” rating and issued a $966.00 price target on shares of McKesson in a research note on Thursday, January 29th. Finally, William Blair started coverage on McKesson in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $968.87.

Check Out Our Latest Stock Report on McKesson

McKesson Stock Performance

Shares of McKesson stock opened at $765.30 on Friday. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The stock’s fifty day moving average is $838.23 and its 200 day moving average is $855.53. The stock has a market cap of $91.99 billion, a P/E ratio of 19.89, a P/E/G ratio of 1.14 and a beta of 0.35.

McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The company had revenue of $96.30 billion for the quarter, compared to analysts’ expectations of $101.35 billion. During the same period last year, the firm earned $10.12 EPS. McKesson’s revenue for the quarter was up 6.0% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Analysts predict that McKesson Corporation will post 44.29 EPS for the current year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson’s dividend payout ratio (DPR) is currently 8.53%.

McKesson Profile

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.